SARS CoV 2 News and Research

RSS

COVID-19 and its effects on the cardiovascular system

Researcher have reviewed the evidence showing the effects of the SARS-CoV-2 or novel coronavirus infection (COVID-19) on the cardiovascular system. Their study titled, “Potential Effects of Coronaviruses on the Cardiovascular System: A Review,” was published in the latest issue of JAMA Cardiology.

29 Mar 2020

CRG launches new database to advance international research efforts on COVID-19

Researchers from the Centre for Genomic Regulation have launched a new database to advance the international research efforts studying COVID-19.

27 Mar 2020

Researchers enlist the help of citizen scientists to design new drugs against coronavirus

The best thing most of us can do to fight COVID-19 is stay home, to curb the respiratory disease's spread. But anyone with a computer can pitch in more actively too: by helping scientists design drugs to combat the virus now responsible for hundreds of thousands of infections worldwide.

27 Mar 2020

UC Davis launches two clinical trials to evaluate treatments for COVID-19

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2.

27 Mar 2020

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Grifols today announces that it has entered into a formal collaboration with the US Government alongside other health agencies, to treat COVID-19 disease.

From GRIFOLS U.K. Ltd. 27 Mar 2020

Outcomes of mothers giving birth during COVID-19 pandemic

Researchers from Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China have looked at the outcomes of pregnant mothers with COVID-19 and their newborns. Their study titled, “Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-center, descriptive study” was published in the latest issue of the journal The Lancet, Infectious Diseases.

26 Mar 2020

Is sex safe during COVID-19 pandemic?

It is not unimaginable that with so many couples locked down within the confines of their homes 24/7, that close physical proximity could result in increased sexual activity, giving rise to questions regarding how safe sex is during these troubled times. COVID-19 disease or infection with the SARS-CoV-2 virus has gripped the world and has taken the form of a pandemic affecting 175 nations and territories across the globe.

26 Mar 2020

New research initiative to investigate multi-species response to novel coronavirus

Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).

26 Mar 2020

Stanford scientists describe potential transmission pathways of COVID-19

Much remains unknown about how SARS-CoV-2, the virus that causes COVID-19, spreads through the environment.

26 Mar 2020

A quest to unlock the genetic code of SARS-CoV-2

How the novel coronavirus that causes COVID-19 made the leap from animals to humans is a puzzle that scientists are trying to solve as humanity comes to grip with the deadly pandemic sweeping the globe.

26 Mar 2020

Frontiers launches Coronavirus Funding Monitor for the research community

Frontiers is dedicating part of its open science platform infrastructure to collect and disseminate information relevant to the research communities battling the COVID-19 pandemic using its Coronavirus Knowledge Hub.

26 Mar 2020

Anteater-like animals are the missing link for coronavirus transmission between bats and humans

As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus' genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares "uncanny similarities" with an HIV-1 protein.

26 Mar 2020

Berkeley Lights Announces GEPAD to Attack COVID-19 and Other Viruses

Today Berkeley Lights, Inc., announced the GEPAD with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples.

From Bruker Cellular Analysis 26 Mar 2020

Murdoch Children's Research Institute to roll-out clinical trial of BCG vaccine against COVID-19

Professor Kathryn North AC, Director of the Murdoch Children's Research Institute in Melbourne, Australia, has announced its infectious disease researchers are preparing to roll-out a multi-center randomized controlled clinical trial of the BCG vaccine against COVID-19.

26 Mar 2020

FDA provides emergency use authorization to PerkinElmer for COVID-19 testing

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test.

From Revvity 26 Mar 2020

What happens when COVID-19 and cardiovascular diseases mix?

The world has been brought to a stand-still by the COVID-19 pandemic that has affected 197 countries, areas and territories, infected 467,594, and killed 21,181 individuals as of today. COVID-19 disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus, contagious in humans.

25 Mar 2020

Transmission of COVID-19 among cancer patients in China

Researchers from Zhongnan Hospital of Wuhan University in China in collaboration with those from the National Cancer Centre Singapore, have come up with a study that reveals the transmission of the SARS-CoV-2 or novel coronavirus among patients with cancer in China.

25 Mar 2020

Coronavirus is not mutating rapidly, hope for vaccine development

Despite the coronavirus infection numbers skyrocketing, there is still good news. A team of scientists found that the novel coronavirus is not mutating significantly, suggesting any vaccine developed to fight SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) would remain effective in the long term.

25 Mar 2020

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

SARS-CoV-2, the virus that causes COVID-19, continues to spread, leading to more than 20,000 deaths worldwide in less than four months. Efforts are progressing to develop a COVID-19 vaccine, but it's still likely 12 to 18 months away.

25 Mar 2020